Journal of Clinical & Experimental Orthopaedics

Description

Fibrous Dysplasia (FD) is a rare, benign bone disorder characterized by the replacement of normal bone with fibrous tissue, leading to bone expansion, deformity, and sometimes fractures. This condition can affect one or multiple bones, with involvement often occurring in the long bones, ribs, skull, and facial bones. Fibrous dysplasia can present in three different forms: Monostotic, which involves a single bone; polyostotic, which affects multiple bones; and McCune-Albright syndrome, a more complex form of polyostotic fibrous dysplasia that includes endocrine abnormalities such as precocious puberty and caféau- lait skin spots. While fibrous dysplasia is typically diagnosed in childhood or adolescence, it may also present in adulthood, although the condition's progression tends to slow with age.

The exact cause of fibrous dysplasia is a mutation in the GNAS gene, which leads to abnormal regulation of osteoblastic differentiation and results in the development of fibrous tissue instead of normal bone. This mutation is somatic, meaning it occurs after conception and is not inherited. As a result, the affected bone areas grow abnormally, causing pain, deformity, and functional impairment. In monostotic fibrous dysplasia, the most common and less severe form, the affected bone may show mild to moderate expansion, and symptoms often remain localized. Polyostotic fibrous dysplasia, however, can cause more widespread bone deformity and pain, particularly when multiple bones are affected, which may lead to significant structural issues, such as limb length discrepancy or scoliosis in the spine. McCune-Albright syndrome, the most severe form of FD, involves not only multiple bone lesions but also endocrine disorders, most notably early puberty in girls, as well as skin pigmentation changes.

Symptoms of fibrous dysplasia can range from being completely asymptomatic to severe, depending on the extent and location of the disease. The most common symptoms are bone pain, which may be dull and aching or more severe, particularly in weight-bearing bones, and deformity, such as limb shortening or bowing. In some cases, patients may experience pathological fractures, which can occur even with minimal trauma due to the weakened bone structure. Neurological symptoms may also develop if the fibrous dysplasia involves bones near the skull, leading to compression of nerves or blood vessels. Diagnosis of fibrous dysplasia is primarily made through imaging, with X-rays, CT scans, and MRI being useful for evaluating the extent of bone involvement. X-rays typically show a characteristic “ground glass” appearance, with the affected bone appearing less dense and more fibrous than normal bone. In cases of polyostotic or complicated FD, advanced imaging may help to assess the involvement of multiple bones and the impact on surrounding soft tissues.

The management of fibrous dysplasia depends on the severity of the symptoms and the extent of the disease. For patients with mild monostotic fibrous dysplasia that does not cause significant pain or deformity, observation is often sufficient, with periodic follow-up to monitor for changes. When FD leads to more significant issues, such as bone deformity or fractures, treatment may involve surgical intervention. Surgery is typically performed to correct deformities, stabilize fractures, or in some cases, remove the abnormal fibrous tissue if it causes functional impairment. However, surgery in FD can be challenging due to the abnormal bone quality, and recurrence of fibrous tissue within the bone may occur after surgery. In cases where FD involves multiple bones or causes severe pain, medications such as bisphosphonates may be used to help reduce pain and improve bone density. Although bisphosphonates do not cure FD, they can slow bone turnover and help in reducing the pain associated with the disease.

For patients with McCune-Albright syndrome, the management is more complex due to the associated endocrine disturbances. Precocious puberty in girls, for instance, may require treatment with hormone therapies to manage early sexual development. Additionally, patients may need regular monitoring for other endocrine issues, such as hyperthyroidism or growth hormone excess. Long-term follow-up is essential for all patients with fibrous dysplasia, especially those with polyostotic FD or McCune-Albright syndrome, as they may experience progressive disease or complications related to bone deformities, fractures, and endocrine dysfunctions.

The prognosis for fibrous dysplasia varies depending on the extent of the disease. Monostotic FD generally has a favorable prognosis, with many patients leading normal lives with minimal intervention. Polyostotic FD and McCune-Albright syndrome, however, can have a more complex and challenging course, requiring ongoing management of both skeletal and endocrine complications. Overall, while fibrous dysplasia is a benign condition, its potential to cause bone deformity, pain, and fractures can lead to significant long-term issues, particularly if left untreated. Early diagnosis and appropriate management are crucial to reducing the impact of the disease and improving quality of life for affected individuals.